These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 26159784)
41. Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Sachs B; Riegel S; Seebeck J; Beier R; Schichler D; Barger A; Merk HF; Erdmann S Drug Saf; 2006; 29(11):1087-100. PubMed ID: 17061914 [TBL] [Abstract][Full Text] [Related]
42. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females? Light KP; Lovell AT; Butt H; Fauvel NJ; Holdcroft A Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):151-60. PubMed ID: 16395661 [TBL] [Abstract][Full Text] [Related]
43. Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database. Petronijevic M; Ilic K; Suzuki A Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):416-23. PubMed ID: 21370308 [TBL] [Abstract][Full Text] [Related]
44. Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs. van Puijenbroek EP; Egberts AC; Heerdink ER; Leufkens HG Eur J Clin Pharmacol; 2000 Dec; 56(9-10):733-8. PubMed ID: 11214785 [TBL] [Abstract][Full Text] [Related]
45. Anaphylactoid reactions to Dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004. Zinderman CE; Landow L; Wise RP J Vasc Surg; 2006 May; 43(5):1004-9. PubMed ID: 16678697 [TBL] [Abstract][Full Text] [Related]
46. [Analysis of clinical use of post-marketing hospital centralized monitoring of Xiyanping injection]. Zhao Y; Shi C; Huang P Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):743-747. PubMed ID: 28871704 [TBL] [Abstract][Full Text] [Related]
47. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections]. Wang HN; Chen W; Fu Z; Du WM; He J Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393 [TBL] [Abstract][Full Text] [Related]
48. [Pilot study for the surveillance of adverse reactions to herbal preparations and dietary supplements]. Menniti-Ippolito F; Mazzanti G; Firenzuoli F; Bianchi A; Raschetti R Ann Ist Super Sanita; 2005; 41(1):39-42. PubMed ID: 16037648 [TBL] [Abstract][Full Text] [Related]
49. The use of Chinese herbal products and its influence on tamoxifen induced endometrial cancer risk among female breast cancer patients: a population-based study. Tsai YT; Lai JN; Wu CT J Ethnopharmacol; 2014 Sep; 155(2):1256-62. PubMed ID: 25048609 [TBL] [Abstract][Full Text] [Related]
50. Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database. Zhao Y; Lu H; Thai S; Li X; Hui J; Tang H; Zhai S; Sun L; Wang T Int J Clin Pharm; 2018 Aug; 40(4):862-869. PubMed ID: 29464448 [TBL] [Abstract][Full Text] [Related]
51. [Analysis of 103 cases with adverse drug reactions induced by sanqizongzaogan injection]. Chen Y; Li Y; Zhu G Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(2):237-9. PubMed ID: 20394303 [TBL] [Abstract][Full Text] [Related]
52. [Post-marketing surveillance of Li XX; Zhuo L; Yang YH; Zhan SY; Zhai SD Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):248-252. PubMed ID: 28231676 [No Abstract] [Full Text] [Related]
53. [Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002)]. Mertes PM; Laxenaire MC; Ann Fr Anesth Reanim; 2004 Dec; 23(12):1133-43. PubMed ID: 15589352 [TBL] [Abstract][Full Text] [Related]
54. Clinical signs and etiology of adverse reactions to procaine benzylpenicillin and sodium/potassium benzylpenicillin in horses. Olsén L; Ingvast-Larsson C; Broström H; Larsson P; Tjälve H J Vet Pharmacol Ther; 2007 Jun; 30(3):201-7. PubMed ID: 17472651 [TBL] [Abstract][Full Text] [Related]
55. Hepatic adverse drug reactions: a case/non-case study in Italy. Motola D; Vargiu A; Leone R; Cocci A; Salvo F; Ros B; Meneghelli I; Venegoni M; Cutroneo PM; Vaccheri A; Velo G; Montanaro N Eur J Clin Pharmacol; 2007 Jan; 63(1):73-9. PubMed ID: 17119945 [TBL] [Abstract][Full Text] [Related]
56. Exploration of statistical shrinkage parameters of disproportionality methods in spontaneous reporting system of China. Wang J; Ye XF; Guo XJ; Zhu TT; Qi N; Hou YF; Zhang TY; Shi WT; Wei X; Liu YZ; Wu GZ; He J Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):962-70. PubMed ID: 26095121 [TBL] [Abstract][Full Text] [Related]
57. Overview of adverse reactions to nefopam: an analysis of the French Pharmacovigilance database. Durrieu G; Olivier P; Bagheri H; Montastruc JL; Fundam Clin Pharmacol; 2007 Oct; 21(5):555-8. PubMed ID: 17868209 [TBL] [Abstract][Full Text] [Related]
58. Acute kidney injury during concomitant use of valacyclovir and loxoprofen: detecting drug-drug interactions in a spontaneous reporting system. Yue Z; Shi J; Jiang P; Sun H Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1154-9. PubMed ID: 24788910 [TBL] [Abstract][Full Text] [Related]
59. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Jose J; Rao PG Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163 [TBL] [Abstract][Full Text] [Related]